Dexcom Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- US stock futures rise as oil pullback amplifies Fed rate-hike boost
- Oil prices extend losses as supply disruption fears ease
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
DexCom (DXCM) PT Raised to $655 at Jefferies
October 29, 2021 7:43 AM EDTJefferies analyst Raj Denhoy raised the price target on DexCom (NASDAQ: DXCM) to $655.00 (from $610.00) while maintaining a Buy rating.
The analyst commented, "XCM posted a $31mn/$0.25 beat on accelerating T2 adoption and OUS momentum which was supplemented by G&A leverage gains.... More
